• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details

Place in Therapy for CGRP Inhibitors for the Treatment of Chronic and Episodic Migraines

Program Type



1.5 Contact Hour(s)

Release Date

Thursday, April 25, 2019

Offline Date:

Monday, October 25, 2021

ACPE Expiration Date

Monday, April 25, 2022

Target Audience




  • Overview

    Patients with episodic or chronic migraines require treatment with a combination of acute and preventative medications. A wide variety of drug classes are currently used for migraine prevention; however, the majority of them are used off-label. CGRP inhibitors are a new class of medications approved for migraine prevention. Pharmacists need to understand the safety and efficacy of these agents, as well as the appropriate patient population, advantages and disadvantages of this new class of drugs.


    Homestudy PDF:   19079H01.pdf

    Financial Support By

    PharmCon, Inc.
  • Pharmacist

    Recognize the available agents for the treatment of chronic and episodic migraines
    Describe the current treatment guidelines for the management of chronic and episodic migraines
    Describe the safety, efficacy, advantages, and disadvantages of CGRP inhibitors
    Identify the place in therapy of the new CGRP inhibitors for the treatment of chronic and episodic migraines

  • Activity Type


    Universal Activity Number

    Pharmacist 0798-0000-19-079-H01-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones

Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Firefox 3.0.3 or higher
Adobe Acrobat Reader

Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).


©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.